Skip to main content

27-05-2020 | Multiple sclerosis | Video

EAN 2020 | Clinical activity predicts interferon-β treatment response in paediatric MS

Ermelinda De Meo outlines research showing clinical activity and ongoing magnetic resonance imaging activity in the first year indicates significant long-term risk of interferon-β treatment failure in paediatric patients with multiple sclerosis (4:36).

Funding for independent interviews at EAN 2020 was provided by F. Hoffmann-La Roche Ltd, Basel, Switzerland.